85 related articles for article (PubMed ID: 7645964)
21. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
[TBL] [Abstract][Full Text] [Related]
22. Absence of p53 gene mutations in primary neuroblastomas.
Vogan K; Bernstein M; Leclerc JM; Brisson L; Brossard J; Brodeur GM; Pelletier J; Gros P
Cancer Res; 1993 Nov; 53(21):5269-73. PubMed ID: 8221661
[TBL] [Abstract][Full Text] [Related]
23. [Detection of p53 mutation using PCR-SSCP silver staining method].
Zhao W; Si J; Li K; Zhang X; Song G
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Jun; 17(3):219-22. PubMed ID: 8706159
[TBL] [Abstract][Full Text] [Related]
24. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
25. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
Komuro H; Hayashi Y; Kawamura M; Hayashi K; Kaneko Y; Kamoshita S; Hanada R; Yamamoto K; Hongo T; Yamada M
Cancer Res; 1993 Nov; 53(21):5284-8. PubMed ID: 8221663
[TBL] [Abstract][Full Text] [Related]
26. Mutations of p53 in Wilms' tumors.
Takeuchi S; Bartram CR; Ludwig R; Royer-Pokora B; Schneider S; Imamura J; Koeffler HP
Mod Pathol; 1995 Jun; 8(5):483-7. PubMed ID: 7675765
[TBL] [Abstract][Full Text] [Related]
27. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy.
Hongyo T; Buzard GS; Palli D; Weghorst CM; Amorosi A; Galli M; Caporaso NE; Fraumeni JF; Rice JM
Cancer Res; 1995 Jun; 55(12):2665-72. PubMed ID: 7780983
[TBL] [Abstract][Full Text] [Related]
28. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
29. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
[TBL] [Abstract][Full Text] [Related]
30. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies].
Kurosawa M
Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179
[TBL] [Abstract][Full Text] [Related]
31. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
32. Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice.
Horio Y; Chen A; Rice P; Roth JA; Malkinson AM; Schrump DS
Mol Carcinog; 1996 Dec; 17(4):217-23. PubMed ID: 8989915
[TBL] [Abstract][Full Text] [Related]
33. Absence of p53 mutations in methylnitrosourea-induced mammary tumors in rats.
Ogawa K; Tokusashi Y; Fukuda I
Cancer Detect Prev; 1996; 20(3):214-7. PubMed ID: 8769715
[TBL] [Abstract][Full Text] [Related]
34. Correlation of frequency of induced mutation and metastatic potential in tumor cell lines from a single mouse mammary tumor.
Yamashina K; Heppner GH
Cancer Res; 1985 Sep; 45(9):4015-9. PubMed ID: 4027998
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous fusion between metastatic mammary tumor subpopulations.
Miller FR; McInerney D; Rogers C; Miller BE
J Cell Biochem; 1988 Feb; 36(2):129-36. PubMed ID: 3356752
[TBL] [Abstract][Full Text] [Related]
36. Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis.
Heinlein C; Krepulat F; Löhler J; Speidel D; Deppert W; Tolstonog GV
Int J Cancer; 2008 Apr; 122(8):1701-9. PubMed ID: 18092324
[TBL] [Abstract][Full Text] [Related]
37. Mammary tumor heterogeneity.
Heppner GH; Loveless SE; Miller FR; Mahoney KH; Fulton AM
Symp Fundam Cancer Res; 1983; 36():209-21. PubMed ID: 6382505
[No Abstract] [Full Text] [Related]
38. Comparison of metastasis of mammary tumors growing in the mammary fatpad versus the subcutis.
Miller FR
Invasion Metastasis; 1981; 1(4):220-6. PubMed ID: 7188387
[TBL] [Abstract][Full Text] [Related]
39. Reduced p53 dosage associated with mammary tumor metastases in C3(1)/TAG transgenic mice.
Maroulakou IG; Shibata MA; Jorcyk CL; Chen XX; Green JE
Mol Carcinog; 1997 Oct; 20(2):168-74. PubMed ID: 9364206
[TBL] [Abstract][Full Text] [Related]
40. [p53 gene mutations in BALB/c 3T3 cells transformed by crocidolite].
Lin F; Zhai C; Liu Y; Zhou G; Sun Z; Li S
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Dec; 28(4):375-9. PubMed ID: 10683950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
